NCT04930406

Brief Summary

This research study will investigate the effect of physical therapy intervention on the function of the foot and ankle in children and adolescents with cancer not involving the brain or spinal cord. Children undergoing treatment for cancer can suffer from decreased flexibility, strength, balance and endurance from the cancer and from direct effects of the chemotherapy agents. These deficits have been shown to continue years after treatment end with adult survivors of cancer being less physically active then their siblings. Children, whose chemotherapy includes neurotoxic agents such as vincristine, can develop damage to their peripheral nervous system affecting the strength, sensation, and flexibility in their hands and feet. This can then lead to a change in their walking pattern and likely contributes to decreased physical activity level and fatigue. The principal investigator is currently involved in research with Dr. Laura Gilchrist and Dr. Mary C. Hooke establishing the reliability and validity of a measurement tool to quantify peripheral neuropathy, identifying physical impairments of children with cancer during treatment, and comparing physical performance in children after treatment completion with and without physical therapy intervention. The principal investigator is also completing data analysis on a pilot study investigating the use of ankle foot orthotics in children and adolescents with non-CNS cancer. In this study, the investigators will further the research by measuring the effect of physical therapy intervention on measurements involving the function and structure of the ankle and foot. The investigators will compare participants who have and have not received physical therapy intervention during cancer treatment by administering measurements detailing the function of the foot and ankle in order to further evaluate the benefit of physical therapy for children with cancer. Physical therapy intervention involving children and adolescents with cancer focuses on minimizing the physical impairments caused by chemotherapy and radiation treatment, as well as promoting normal development of motor skills typically obtained by a child in their age group. In the oncology population, physical therapy often targets the foot and ankle as this is most affected by peripheral neuropathy. Interventions include strengthening, balance training, stretching, and orthotic use to allow normal motor skills. Families are instructed in exercises that can be completed at home to further improve their function. This study will examine the difference in the function of the foot and ankle years after intervention in participants who have and have not received these interventions. The investigators will measure neuropathy, ankle flexibility, ankle strength, foot posture, gait mechanics, and endurance in order to fully examine the foot and ankle as well as evaluate relationships between the variables in long-term survivors of pediatric cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2012

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

April 27, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 18, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2021

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

9 years

First QC Date

April 27, 2021

Last Update Submit

February 16, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Ankle range of motion

    Active and passive ankle range of motion measured by goniometry

    One day study

  • Ankle strength

    Ankle plantarflexion and dorsiflexion dynamometry and manual muscle testing of ankle dorsiflexion and great toe extension

    One day study

Secondary Outcomes (7)

  • Chemotherapy-induced peripheral neuropathy

    One day study

  • Foot posture

    One day study

  • Gait capacity

    One day study

  • Gait

    One day study

  • Running speed

    One day study

  • +2 more secondary outcomes

Study Arms (2)

Historical control group

Intervention group

Other: Physical therapy

Interventions

Had to receive 10 or more visits of physical therapy during the cancer treatment period to qualify for intervention group.

Intervention group

Eligibility Criteria

Age7 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Diagnosed with a non-CNS cancer diagnosis with chemotherapy regimen including vincristine, carboplatin, or cisplatin greater than 5 years off of cancer treatment

You may qualify if:

  • Historical control group
  • Children and adolescents age 7-30
  • English speaking family
  • Diagnosed with a non-CNS cancer diagnosis with chemotherapy regimen including vincristine, carboplatin, or cisplatin
  • Completed cancer treatment greater than 5 years ago
  • Received less than 2 intervention visits of outpatient physical therapy during cancer treatment
  • Intervention group
  • Children and adolescents age 7-30
  • English speaking family
  • Completed cancer treatment greater than 5 years ago
  • Greater than 10 physical therapy visits at Children's Hospitals and Clinics of MN
  • Received PT evaluation within 6 months of starting cancer treatment.

You may not qualify if:

  • Neurological impairments prior to cancer diagnosis
  • Developmental disorders (Downs syndrome, chromosomal disorders)
  • Non-English speaking parent/child
  • Lower extremity or pelvic surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Minnesota

Minneapolis, Minnesota, 55404, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms

Interventions

Physical Therapy Modalities

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2021

First Posted

June 18, 2021

Study Start

December 18, 2012

Primary Completion

December 13, 2021

Study Completion

December 31, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Locations